Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
Context: Heart failure (HF) is one of the most serious diseases worldwide. Astragaloside IV (ASI) is widely used for the treatment of cardiovascular disease in China. Objective: To evaluate the protective effect of ASI on the HF in a Sprague–Dawley rat model of left coronary artery ligation, and inv...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Taylor & Francis Group
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/30fc41ab8e72464fab9085b4d9139a56 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|